{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:54:58Z","timestamp":1790902498935,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008741","name":"EULAR","doi-asserted-by":"publisher","award":["CLI113"],"award-info":[{"award-number":["CLI113"]}],"id":[{"id":"10.13039\/501100008741","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ero.2025.05.004","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:14:47Z","timestamp":1765541687000},"page":"100020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Items identified by expert physicians for the development of the criteria for the assessment of disease activity for adult-onset Still's disease: results of a web-based Delphi study informing the development of the European Alliance of Associations for Rheumatology (EULAR) criteria for the assessment of disease activity in these patients"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5244-7881","authenticated-orcid":false,"given":"St\u00e9phane","family":"Mitrovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4901-2059","authenticated-orcid":false,"given":"Charlotte","family":"Girard-Guyonvarc\u2019h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3487-8551","authenticated-orcid":false,"given":"Piero","family":"Ruscitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-3063","authenticated-orcid":false,"given":"Cem","family":"Gabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-7406","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Gonzalez-Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9872-5282","authenticated-orcid":false,"given":"Eugen","family":"Feist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0670-9638","authenticated-orcid":false,"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3073-7284","authenticated-orcid":false,"given":"Tanja","family":"Stamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8845-4274","authenticated-orcid":false,"given":"Bruno","family":"Fautrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2025.05.004_bib0001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still\u2019s disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.ero.2025.05.004_bib0002","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","article-title":"Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease","volume":"14","author":"Feist","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.ero.2025.05.004_bib0003","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12916-016-0738-8","article-title":"Adult-onset Still\u2019s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers","volume":"14","author":"Ruscitti","year":"2016","journal-title":"BMC Med"},{"issue":"2","key":"10.1016\/j.ero.2025.05.004_bib0004","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.1780300209","article-title":"Adult-onset still\u2019s disease. Clinical course and outcome","volume":"30","author":"Cush","year":"1987","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ero.2025.05.004_bib0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/ard.54.7.587","article-title":"Epidemiology of adult Still\u2019s disease: estimate of the incidence by a retrospective study in west France","volume":"54","author":"Magadur-Joly","year":"1995","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ero.2025.05.004_bib0006","first-page":"1058","article-title":"Adult Still\u2019s disease: a multicenter survey of Japanese patients","volume":"17","author":"Ohta","year":"1990","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.ero.2025.05.004_bib0007","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still\u2019s disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.ero.2025.05.004_bib0008","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ncprheum0510","article-title":"Adult-onset Still\u2019s disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?","volume":"3","author":"Efthimiou","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"11","key":"10.1016\/j.ero.2025.05.004_bib0009","first-page":"758","article-title":"Adult Still\u2019s disease. Part II. Management, outcome, and prognostic factors","volume":"62","author":"Masson","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"issue":"6","key":"10.1016\/j.ero.2025.05.004_bib0010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3899\/jrheum.170955","article-title":"Macrophage activation syndrome in patients affected by adult-onset Still disease: analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort","volume":"45","author":"Ruscitti","year":"2018","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.ero.2025.05.004_bib0011","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/1744666X.2018.1465821","article-title":"Complications of adult-onset Still\u2019s disease and their management","volume":"14","author":"Mitrovic","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.ero.2025.05.004_bib0012","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.berh.2016.08.003","article-title":"Adult-onset Still\u2019s disease: advances in the treatment","volume":"30","author":"Casta\u00f1eda","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.ero.2025.05.004_bib0013","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1080\/1744666X.2017.1375853","article-title":"Biologic drugs in adult onset Still\u2019s disease: a systematic review and meta-analysis of observational studies","volume":"13","author":"Ruscitti","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.ero.2025.05.004_bib0014","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.semarthrit.2017.06.006","article-title":"Adult onset Still\u2019s disease\u2014the evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)","volume":"47","author":"Junge","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ero.2025.05.004_bib0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/ard.2009.108068","article-title":"IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still\u2019s disease","volume":"69","author":"Naumann","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ero.2025.05.004_bib0016","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.2006.066381","article-title":"Anakinra treatment in patients with adult-onset Still\u2019s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial","volume":"66","author":"Kalliolias","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2025.05.004_bib0017","first-page":"2345","article-title":"Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety","volume":"8","author":"Hong","year":"2014","journal-title":"Drug Des Devel Ther"},{"issue":"12","key":"10.1016\/j.ero.2025.05.004_bib0018","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1136\/annrheumdis-2012-201409","article-title":"IL-1 Trap rilonacept in refractory adult onset Still\u2019s disease","volume":"71","author":"Petryna","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ero.2025.05.004_bib0019","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.semarthrit.2012.03.004","article-title":"The use of canakinumab, a novel IL-1\u03b2 long-acting inhibitor, in refractory adult-onset Still\u2019s disease","volume":"42","author":"Kontzias","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.ero.2025.05.004_bib0020","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/ard-2024-225851","article-title":"EULAR\/PReS recommendations for the diagnosis and management of Still\u2019s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease","volume":"83","author":"Fautrel","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ero.2025.05.004_bib0021","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.3899\/jrheum.100783","article-title":"Scoring adult-onset Still\u2019s disease","volume":"37","author":"Mueller","year":"2010","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.ero.2025.05.004_bib0022","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/ard.2004.024026","article-title":"Club Rhumatismes et Inflammation. Tumour necrosis factor alpha blocking agents in refractory adult Still\u2019s disease: an observational study of 20 cases","volume":"64","author":"Fautrel","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ero.2025.05.004_bib0023","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.2007.076034","article-title":"Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France","volume":"67","author":"Lequerr\u00e9","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ero.2025.05.004_bib0024","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3899\/jrheum.100247","article-title":"Clinical manifestations but not cytokine profiles differentiate adult-onset Still\u2019s disease and sepsis","volume":"37","author":"Rau","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ero.2025.05.004_bib0025","unstructured":"European Alliance of Associations for Rheumatology (EULAR). CLI113 - Development And Validation of a EULAR disease activity score in adult onset Still's Disease: the \u201cDAVID\u201d project. Roberto Giacomelli. Available from: Ongoing Initiatives | EULAR https:\/\/www.eular.org\/ongoing-initiatives."},{"key":"10.1016\/j.ero.2025.05.004_bib0026","series-title":"The Delphi method: an experimental study of group opinion","first-page":"79","author":"Dakley","year":"1969"},{"issue":"7001","key":"10.1016\/j.ero.2025.05.004_bib0027","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","article-title":"Consensus methods for medical and health services research","volume":"311","author":"Jones","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.ero.2025.05.004_bib0028","series-title":"The Delphi method: techniques and applications","first-page":"620","author":"Linstone","year":"1975"},{"issue":"1","key":"10.1016\/j.ero.2025.05.004_bib0029","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/art.24165","article-title":"Identification of relevant concepts of functioning in daily life in people with systemic lupus erythematosus: a patient Delphi exercise","volume":"61","author":"Bauernfeind","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ero.2025.05.004_bib0030","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/art.10231","article-title":"Etanercept in the treatment of adult patients with Still\u2019s disease","volume":"46","author":"Husni","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ero.2025.05.004_bib0031","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/14397595.2014.899178","article-title":"Successful tocilizumab therapy in seven patients with refractory adult-onset Still\u2019s disease","volume":"26","author":"Bannai","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.ero.2025.05.004_bib0032","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/acr.20319","article-title":"Tocilizumab in refractory adult Still\u2019s disease","volume":"63","author":"Pu\u00e9chal","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.ero.2025.05.004_bib0033","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/acr.21901","article-title":"Anakinra in adult-onset Still\u2019s disease: long-term treatment in patients resistant to conventional therapy","volume":"65","author":"Giampietro","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"10","key":"10.1016\/j.ero.2025.05.004_bib0034","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3899\/jrheum.111549","article-title":"Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still\u2019s disease. An open, randomized, multicenter study","volume":"39","author":"Nordstr\u00f6m","year":"2012","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.ero.2025.05.004_bib0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/03009742.2014.992949","article-title":"Efficacy and safety of biological agents in adult-onset Still\u2019s disease","volume":"44","author":"Cavalli","year":"2015","journal-title":"Scand J Rheumatol"},{"issue":"12","key":"10.1016\/j.ero.2025.05.004_bib0036","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1136\/annrheumdis-2018-213920","article-title":"Tocilizumab in patients with adult-onset still\u2019s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial","volume":"77","author":"Kaneko","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ero.2025.05.004_bib0037","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jbspin.2017.05.011","article-title":"New markers for adult-onset Still\u2019s disease","volume":"85","author":"Mitrovic","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.ero.2025.05.004_bib0038","first-page":"1203","article-title":"Health status instruments \/utilities","volume":"22","author":"Bellamy","year":"1995","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.ero.2025.05.004_bib0039","first-page":"1648","article-title":"Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria","volume":"30","author":"Pham","year":"2003","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.ero.2025.05.004_bib0040","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13075-016-1151-6","article-title":"Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature","volume":"18","author":"Nikiphorou","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.ero.2025.05.004_bib0041","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.ero.2025.05.004_bib0042","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00005792-200205000-00003","article-title":"Proposal for a new set of classification criteria for adult-onset still disease","volume":"81","author":"Fautrel","year":"2002","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.ero.2025.05.004_bib0043","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","article-title":"Adult-onset Still disease","volume":"22","author":"Fautrel","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.ero.2025.05.004_bib0044","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still\u2019s disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.ero.2025.05.004_bib0045","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaad.2018.05.020","article-title":"Increased severity and epidermal alterations in persistent versus evanescent skin lesions in adult-onset Still disease","volume":"79","author":"Zuelgaray","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ero.2025.05.004_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094024","article-title":"A web-based Delphi study for eliciting helpful criteria in the positive diagnosis of hemophagocytic syndrome in adult patients","volume":"9","author":"Hejblum","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ero.2025.05.004_bib0047","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1378\/chest.06-3014","article-title":"A web-based Delphi study on the indications of chest radiographs for patients in ICUs","volume":"133","author":"Hejblum","year":"2008","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ero.2025.05.004_bib0048","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1525822X08317085","article-title":"Comparing response rates from web and mail surveys: a meta-analysis","volume":"20","author":"Shih","year":"2008","journal-title":"Field Methods"},{"issue":"2","key":"10.1016\/j.ero.2025.05.004_bib0049","first-page":"119","article-title":"Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"Am Stat"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:20:48Z","timestamp":1790900448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708125000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S3050708125000321"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.05.004","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Items identified by expert physicians for the development of the criteria for the assessment of disease activity for adult-onset Still's disease: results of a web-based Delphi study informing the development of the European Alliance of Associations for Rheumatology (EULAR) criteria for the assessment of disease activity in these patients","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.05.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}],"article-number":"100020"}}